Top Health Tech Companies in Melbourne (62)
The International SOS Group of Companies is in the business of saving lives, protecting global workforces from health and security threats. We deliver customised health, security risk management and wellbeing solutions to fuel our clients’ growth and productivity. In the event of extreme weather, an epidemic or a security incident, we provide an immediate response providing peace of mind. Our...
Acrux is a specialty pharma company with a successful track record of developing and commercialising a pipeline of topically applied pharmaceutical products. Drawing on 25 years of experience, Acrux has successfully marketed through licensees a number of products worldwide with emphasis on the United States. Acrux is formulating and developing a range of topical generic products by leveraging its highly...
CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; NASDAQ INTERNATIONAL DESIGNATION ADR: CLVLY; XETRA-DAX: UR9) is a global and diversified biopharmaceutical company focused on developing and commercialising treatments for patients with genetic, metabolic, and life-threatening disorders, as well as healthcare solutions for the general population. As pioneers in photomedicine and understanding the interaction of light and human biology, CLINUVEL’s research and development has...
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com. Together with...
Stryker's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show double-digit annual sales expansion through 2025, with management guiding to continued organic growth into 2026.
Strong Market Position & Advantage: Evidence highlights leadership in orthopedic robotics and top-tier standings among global medtech peers, with notable share in joint replacement and integrated OR technologies.
Diversified Revenue Streams: Multiple segments and recent vascular-focused acquisitions broaden growth drivers and reduce reliance on any single category.
Montu is the leading medical cannabis company committed to improve the lives of millions of patients.
Abano Healthcare is Australasia's largest dental support organization, providing essential support services to clinical partners across its network of general dental and specialist practices.
MSI Reproductive Choices provides contraception and abortion services that enable women worldwide to choose their futures. Its mission is to ensure everyone, everywhere, has reproductive choice, and it delivers and expands high-quality contraception and abortion services around the world. Its 9,000 team members work across six continents, delivering reproductive healthcare and supporting people in making choices about their bodies and...
Sentec AG is a Swiss-American medical device company specializing in respiratory care, developing, manufacturing, and marketing innovative high-tech sensors and non-invasive monitoring solutions.
American Express Global Business (Amex GBT) is the world’s leading B2B travel platform, providing software and services to manage travel, expenses, meetings & events for companies of all sizes. Our solutions include: Egencia: the leading software as service travel platform for small and medium-sized enterprises (SMEs). Ovation: the solution synonymous with high-touch travel service. The Neo Technology Group: a technology-focused team that builds...
American Express Global Business Travel's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is positioned as a top-tier global corporate travel management provider, with multiple references to leading rankings and scale leadership in managed corporate travel. The CWT acquisition is presented as further consolidating market share and expanding footprint and negotiating leverage.
Strong Revenue Growth: Revenue and adjusted EBITDA are described as rising across 2024 and through 2025, alongside raised guidance, indicating continued top-line momentum. Growth is attributed to both organic wins/transactions and acquisition contribution.
Profitability: Margins and adjusted EBITDA are described as expanding, indicating improving earnings capacity and operating leverage. Share repurchase expansion is framed as a signal of confidence in cash generation and profitability trajectory.
Umps is a Victorian health-tech company redefining the personal alarm industry to help older adults and NDIS participants stay safe, independent and healthy at home for longer. Our flagship product, the Umps Link Home Alarm, is the culmination of six years of dedicated research and development, designed in collaboration with some of the largest aged care providers in Victoria and...
Nucleus Global is the largest specialist medical communications company in the world. Built on a reputation of scientific excellence and quality, we are a global leader in delivering world-class, innovative education and medical marketing services to the pharmaceutical and biotechnology industries.
Covidence is a non-profit social enterprise and global SaaS platform dedicated to accelerating the creation of systematic reviews for the evidence community. It provides a collaborative workflow tool used by leading institutions to streamline citation screening, full-text review, risk of bias assessment, and data extraction, helping researchers transform scientific research into trustworthy and actionable summaries of knowledge.
Teladoc Health is on a mission to empower all people everywhere to live healthier lives by transforming the healthcare experience. Recognized as the world leader in whole-person virtual care, Teladoc Health addresses the full spectrum of health and well-being — powered by human expertise, advanced technology and insights—to deliver improved clinical outcomes at scale. Serving more than 175 countries and...
Teladoc Health's Top Stability & Growth Strengths
Strong Market Position & Advantage: Scale across enterprise and direct‑to‑consumer channels (including 17.1 million visits in 2025) and a broad integrated‑care stack position the company as a top multi‑specialty virtual‑care operator. External signals such as BetterHelp’s category scale and a top‑tier satisfaction ranking support durable competitive standing.
Cost & Operational Efficiency: Operating performance shows improving efficiency with a materially narrower net loss and stable adjusted EBITDA despite revenue pressure. Margin expansion in Integrated Care indicates better unit economics at scale.
Market Expansion: International revenue grew while insurance acceptance for BetterHelp expanded and new channels were pursued, signaling ongoing market expansion. These moves diversify geography and payer mix beyond U.S. cash‑pay exposures.
Medtronic is a global healthcare solutions company operating in approximately 160 countries. We are committed to improving lives through our medical technologies, services, and solutions. Since our beginning, 60 years ago, our Mission has remained the same: to alleviate pain, restore health, and extend life for people around the world. The Mission is our ethical framework and inspirational goal guiding...
Medtronic's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue accelerated to the fastest annual pace in a decade in FY2026, with momentum evident into the fourth quarter. Management’s outlook points to continued upper single‑digit organic expansion in the coming year.
Healthy Cash Flow: Strong free cash flow and a long-running pattern of dividend increases indicate durable cash generation. Recent dividend actions and ongoing cash returns underscore capacity to fund investment and tuck‑in M&A.
Strong Market Position & Advantage: Scale leadership at the top of global medtech by revenue, with breadth across Cardiovascular, Neuroscience, and Medical Surgical, supports resilience. Category strength in areas like cardiac pacing and ablation provides commercial leverage for new launches.
Bupa's purpose is helping people live longer, healthier, happier lives and making a better world. We are an international healthcare company serving over 38 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers. We directly employ around 85,000 people, principally in the UK, Australia, Spain, Chile, Poland, New...
Bupa's Top Stability & Growth Strengths
Strong Revenue Growth: Group results show double‑digit revenue and underlying profit growth in 2024, with customers rising sharply. 2025 materials indicate continued revenue and profit increases alongside a larger customer base, with growth remaining solid even excluding first‑time consolidation effects.
Strong Market Position & Advantage: Independent market analysis places Bupa as the UK PMI leader within a concentrated 'big four', and official statistics show it as the largest fund in Australian private health insurance. Bupa Global is viewed as a tier‑one IPMI provider, and the insurer‑plus‑provider model strengthens competitive positioning across multiple regions.
Market Expansion: Company updates highlight ongoing expansion of clinics, dental centres, hospitals and digital health (Blua), with dozens of new sites opened in 2024 and further additions in 2025. Portfolio moves such as consolidating Niva Bupa in India and adding UK provision assets broaden reach into fast‑growing markets and channels.
The Walter and Eliza Hall Institute of Medical Research (WEHI) is a medical research institute dedicated to improving health outcomes through discovery, translation, and education. WEHI focuses on developing treatments for cancer, immune disorders, infections, and diseases of development and ageing, collaborating to make life-changing scientific discoveries that help people live healthier, longer lives.
PKG Health believes every person with a neurological condition deserves to live their best life every day. We leverage the world’s largest body of clinical evidence in neurology, to create and deliver precision medicine by accelerating the research, approval and adoption of treatments. Its lead product, the Parkinson's KinetiGraph®(PKG® or Personal KinetiGraph® in the US), has been developed by neurologists...
Doctify is a high-growth HealthTech company revolutionising the global healthcare market. Having expanded into 6 markets with an ambitious growth plan over the coming year. Doctify has developed a first-of-its-kind healthcare-specific patient feedback and review product allowing healthcare professionals to drive improvements in patient care on a daily basis. Our SaaS product allows healthcare providers to collect and digitize patient feedback and...
ProPharma is the premier Research Consulting Organization (RCO), delivering fully customizable consulting solutions to empower biotech, med device, and pharmaceutical organizations of all sizes to advance scientific breakthroughs confidently and introduce new therapies. With over 20 years of expertise in regulatory sciences, clinical research solutions, quality & compliance, pharmacovigilance, medical information, and R&D technology, ProPharma partners with clients across the...
ProPharma's Top Stability & Growth Strengths
Market Expansion: Feedback suggests the company is broadening its global footprint, including opening a new office in Hyderabad and expanding across Central and Eastern Europe via acquisitions. These moves indicate a focus on scaling operations and accessing new markets.
Strategic Partnerships: Feedback suggests targeted acquisitions such as Clinres Farmacija and Digital Lab Consulting are used to enhance capabilities and geographic reach. These integrations appear to strengthen end-to-end service coverage across regulatory, clinical, and R&D functions.
Strong Brand Reputation: Feedback suggests multiple industry awards and recognitions, including CPHI and CRO Leadership distinctions, bolster standing as a top-tier provider. External analyst mentions, such as Everest Group’s PEAK Matrix designation, reinforce credibility.
Smileyscope is a multi-award winning digital therapeutics company with proprietary technology that reframes medical procedures using choreographed virtual-reality (VR) experiences to help reduce patient pain and anxiety, and improve the overall patient experience. Our vision is to expand the frontiers of patient-centered care, improving the moments that matter most. Smileyscope VR is the first regulatory body approved VR product for...
